Copley to launch new breath simulator for inhaler testing

Copley to launch new breath simulator for inhaler testing
Copley Scientific says new ‘breath simulator’ will let developers predict real world DPI and MDI performance more accurately. 

The tech – BRS 3000 – allows users to specify precise breathing profiles that – according to Copley – more closely mimic patient use of inhalers in the real-world.

It has a maximum inhalation volume of 5 litres and has flow rate and flow rate acceleration capabilities that allow for “the demands of MDI and DPI testing, when powerful inhalation-only manoeuvres are required​.”

The system – which will be launched at Respiratory Drug Delivery (RDD) in San Diego, US in May – is designed as a companion technology to the BRS 2000 nebulizer testing platform that UK-based Copley rolled out in 2011.

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us

Products

View more

Webinars